Technology Platform

By leveraging complex unit-cell architectures, high-speed additive manufacturing and clinically-proven materials, BellaSeno is redefining the possibilities of scaffold architecture, aesthetics, performance and scalability.

Key features of Yasham technology platform:

Broad spectrum of design possibilities

Enabled by BellaSeno’s custom design software, the 3D unit-cell based architectures optimize strength and flexibility. Fully open porous design enables full integration of the implant into the body (i.e. no encapsulation) and vascularization at the regeneration site.

Cost-effective mass personalization

Additive manufacturing provides full flexibility in product range — off-the-shelf, mass personalized or fully custom-made scaffolds.

Clinically proven materials

Used in unprecedented ways to achieve new levels of safety and performance at scale:

  • Wide range of material options to address any application
  • Multifunctional parts through multi-material integration and heterogenous designs.
  • Robust GMP-grade supply chain of clinically proven materials.

AI-driven no-touch manufacturing — safety by design

BellaSeno is building the world’s first AI-driven additive manufacturing facilities based on the so-called no-touch approach: intelligent software and robotics to significantly improve the safety and sterility of medical implants.

Quality at heart

ISO-13485 certification, repeatable process, reliable equipment and end-to-end GMP-grade supply chains.


  1. PCT/EP2015/070599, 2014: Scaffold design for breast reconstruction
  2. EP17211009.0, 2017: In-process QA for AM
  3. PCT/EP2019/065264, 2019: Scaffold porous architecture
  4. EP20155109.0, 2020: In-process QA for AM
  5. EP19195332.2, 2019: Scaffold design + mechanical features
  6. EP20186961.7, 2020: Scaffold porous architecture
  7. EP17211010.8, 2017: In-process QA for AM
  8. Design Patent: 008050231, 2020: Breast scaffold
  9. EP21210882.3, 2021: Manufacturing process